Prognostic Factors in Cancer, Third Edition amends and streamlines the authoritative monograph on prognostic factors and their use in planning treatment for cancer patients. The text is an extension of the International Union Against Cancer's (UICC) seminal work, the TNM Classification of Malignant Tumours, and integrates the current focus on prognostics in cancer. The Tumor-Node-Metastasis (TNM) classification remains the most widely used system for staging the progression of cancer and is the single most important predictive indicator for outcomes. Prognostic Factors in Cancer, Third Edition is divided into two parts. The first section provides an update on the science of prognosis in general and prognosis in cancer patients in particular, including issues surrounding accuracy of measurement of prognosis and methodology of studying and classifying prognostic factors. That section also introduces the timely topic of incorporating molecular oncology into prognosis. The second section consists of site-specific or tumor-specific chapters and the prognostic factors associated with particular malignancies. These chapters contain an overview of the relevant literature and include tables that classify prognostic factors according to variable circumstances (tumor and non-tumor subjects) and relevance. Prognostic Factors in Cancer, Third Edition illustrates the scope of the field as it stands today. It imparts a perspective on likely outcomes of neoplastic disease that is an increasingly useful tool for physicians and all others responsible for the care of patients with cancer. Visit TNM Online at: www.mrw.interscience.wiley.com/tnm to find the complete text of the previous edition of Prognostic Factors in Cancer, as well as other supplemental material related to cancer staging and predictive indicators. "This is a well organized and...comprehensive book...a quick reference that brings together state-of-the-art knowledge for numerous tumor types." (Doody's Health Services) "...one of only textbooks of its kind to focus on the clinical methodology for evaluating prognostic factors in order to arrive at humane and effective treatments for the cancer-sick patient." (Electric Review, September/October 2006)